Priming treatment with T-cell redirecting bispecific antibody ERY974 reduced cytokine induction without losing cytotoxic activity in vitro by changing the chromatin state in T cells

Iwata, Y., Narushima, Y., Harada, A. and Mishima, M. Priming treatment with T-cell redirecting bispecific antibody ERY974 reduced cytokine induction without losing cytotoxic activity in vitro by changing the chromatin state in T cells. Toxicology And Applied Pharmacology. 2022; 441, 115986. doi: 10.1016/j.taap.2022.115986

Date

BioLife Solutions Symbol

This website uses cookies to ensure you get the best experience on our website.